Vericel Posts MACI 1Q18 Revenue Growth

By Julie A. Vetalice

For 1Q18, Vericel posted orthobiologic revenue of US $12.1MM, +142% vs. 1Q17.

Member-Only Content

SUBSCRIBE Login

Product Labels: Orthobiologic Soft Tissue Repair

Tags: Revenue Report